Simple coagulation tests improve survival prediction in patients with septic shock

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 4, 2008, Pages 645-653

  Lissalde Lavigne, Geraldine ^a,b,c   Combescure, C ^a   Muller, L ^b   Bengler, C ^a   Raillard, A ^a   Lefrant, J Y ^a   Gris, J C ^b  

^a NÎMES UNIVERSITY HOSPITAL   (France)

^b UNIV MONTPELLIER   (France)

^c DEPARTMENT OF NEUROLOGY   (France)

Author keywords

Coagulation; Mortality; Sepsis; Shock

Indexed keywords

ANTIINFECTIVE AGENT; ANTITHROMBIN; CORTICOSTEROID; FIBRINOGEN; FRESH FROZEN PLASMA; HEMOGLOBIN; HEPARIN; PROTHROMBIN; THROMBOCYTE CONCENTRATE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD CELL COUNT; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; CLINICAL ASSESSMENT TOOL; CRITICALLY ILL PATIENT; DIAGNOSTIC VALUE; DISSEMINATED INTRAVASCULAR CLOTTING; ERYTHROCYTE CONCENTRATE; FIBRINOGEN BLOOD LEVEL; FLUID RESUSCITATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MORTALITY; MULTIPLE ORGAN FAILURE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; SENSITIVITY AND SPECIFICITY; SEPSIS RELATED ORGAN FAILURE ASSESSMENT SCORE; SEPTIC SHOCK; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; SURVIVAL; SURVIVAL RATE; THROMBOCYTOPENIA;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BLOOD CELL COUNT; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; COMBINED MODALITY THERAPY; COMORBIDITY; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; FOLLOW-UP STUDIES; FRANCE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PREDICTIVE VALUE OF TESTS; ROC CURVE; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; SURVIVAL ANALYSIS;

EID: 40949121909     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.02895.x     Document Type: Article

References (31)

1. Herridge MS. Prognostication and intensive care unit outcome: The evolving role of scoring systems. Clin Chest Med 2003; 24: 751-6.
2. Beal AL, Cerra FB. Multiple organ failure syndromes in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA 1994; 271: 226-33.
3. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957-63.
4. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707-10.
5. Cornet AD, Issa AI, van de Loosdrecht AA, Ossenkoppele GJ, Strack van Schijndel RJ, Groeneveld AB. Sequential organ failure predicts mortality of patients with a haematological malignancy needing intensive care. Eur J Haematol 2005; 74: 511-6.
6. Nfor TK, Walsh TS, Prescott RJ. The impact of organ failures and their relationship with outcome in intensive care: Analysis of a prospective multicenter database of adult admissions. Anaesthesia 2006; 61: 731-8.
7. Ohno-Machado L, Resnic FS, Matheny ME. Prognosis in critical care. Annu Rev Biomed Eng 2006; 8: 567-99.
8. Zygun DA, Lauplan KB, Fick GH, Sandham JD, Doig CJ. Limited ability of SOFA and MOD scores to discriminate outcome: A prospective evaluation in 1,436 patients. Can J Anaesth 2005; 52: 302-8.
9. Amaral A, Opal SM, Vincent JL. Coagulation in sepsis. Intensive Care Med 2004; 30: 1032-40.
10. Wada H, Wakita Y, Nakase T. Outcome prediction of dissemination intravascular coagulation in relation to the score when treatment was begun. Thromb Haemost 1995; 78: 848-52.
11. Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on 'sepsis-related problems'of the European Society of Intensive Care Medicine. Crit Care Med 1998; 26: 1793-800.
12. Beltran J, Combot C, Grosley M, Nicham F, Woodhams B. A new fully automated assay for TAFI determination-STAR® Stachrom® TAFI. XXth ISTH Congress, Sydney, Autralia, 2005. J Thromb Haemost 2005; 3 (Suppl. 1): P1296.
13. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86: 1327-30.
14. Bakhtiari K, Meijers JCM, de Jonge E, Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004; 32: 2416-21.
15. Hamano A, Umeda M, Ueno Y, Tanaka S, Mimuro J, Sakata Y. Latex immunoturbidimetric assay for soluble fibrin complex. Clin Chem 2005; 51: 183-8.
16. Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, Mayumi T, Mura A, Ikeda T, Ishukura H, Ueyama M, Ogura H, Kushimoto S, Saitoh D, Endo S, Shimazaki S. A multicenter prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: Comparing current criteria. Crit Care Med 2006; 34: 625-31.
17. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
18. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988; 44: 837-45.
19. Le Gall JR, Neumann A, Hemmery F, Bleriot JP, Fulgencio JP, Garrigues B, Gouzes C, Lepage E, Moine P, Villers D. Mortality prediction using SAPS-II: An update from French intensive care units. Crit Care 2005; 9: R645-R652.
20. Brauner JS, Rohde LE, Clausell N. Circulating endothelin-1 and tumor necrosis-factor alpha: Early predictors of mortality in patients with septic shock. Intensive Care Med 2000; 26: 305-13.
21. Martins GA, Da Glorai Da Costa Carvalho M, Rocha Gattass C. Sepsis: A follow-up of cytokine production in different phases of septic patients. Int J Mol Med 2003; 11: 585-91.
22. Gogos CA, Lekkou A, Papageorgiou O, Siagris D, Skoutelis A, Bassaris HP. Clinical prognostic markers in patients with severe sepsis: A prospective analysis of 139 consecutive cases. J Infect 2003; 47: 300-6.
23. Voves C, Wuillemin WA, Zeerleder S. International society on thrombosis and haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients. Blood Coagul Fibrinol 2006; 17: 445-51.
24. Angstwurm MWA, Dempfle CE, Spannagl M. New disseminated intravascular coagulation score: A useful tool to predict mortality in comparison with acute physiology and chronic health evaluation II and logistic organ dysfunction scores. Crit Care Med 2006; 34: 314-20.
25. Dhainaut JF, Shorr AF, Macias WL, Kollef MJ, Levi M, Reinhart K, Nelson DR. Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med 2005; 33: 341-8.
26. Bernard GR, Ely EW, Wright TJ, Fraiz J, Stasek JE Jr, Russel JA, Mayers I, Rosenfeld BA, Morris PE, Yan SB, Helterbrand JD. Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis. Crit Care Med 2001; 29: 2051-9.
27. Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, Marey A, Lestavel P. Septic shock, multiple organ failure and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992; 101: 816-23.
28. Wiedermann CJ, Hoffmann JN, Juers M, Ostermann H, Kienast J, Briegel J, Strauss R, Keinecke HO, Warren BL, Opal SM, KyberSept Investigators. High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: Efficacy and safety. Crit Care Med 2006; 34: 285-92.
29. Hoffmann JN, Mühlbayer D, Jochum M, Inthorn D. Effect of long-term and high-dose antithrombin supplementation on coagulation and fibrinolysis in patients with severe sepsis. Crit Care Med 2004; 32: 1851-9.
30. Dhainaut JF, Yan SB, Joyce DE, PettiläV, Basson B, Brandt JT, Sundin DP, Levi M. Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2005; 2: 1924-33.
31. Saito H, Maruyama I, Shimazaki S, Yamamoto Y, Aikawa N, Ohno R, Hirayama A, Matsuda T, Asakura H, Nakashima M, Aoki N. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: Results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost 2007; 5: 31-41.